Skip to main content
Caplight Logo









StemcellX

StemcellX

Private
SheffieldHealthcare & Life Scienceshttps://stemcellx.com

Momentum

Top 25%

of companies Caplight tracks

Company Overview

StemcellX operates in Healthcare & Life Sciences and is based in Sheffield. It was founded in 2015.

StemcellX is a biotechnology company that develops mesenchymal stem cell-based regenerative therapies for the treatment of osteoarthritis in animals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

StemcellX Comparables

Compare StemcellX with similar companies based on industry and business-model similarity.

StemcellX comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EquiCord
95%
Medrego
88%
Gallant
86%
Book a demo to see all comparables

For institutional investors. Book with your work email.

StemcellX Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for StemcellX. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Endre Kiss-Toth

CEO at Stem CellX Limited

Executive Team

Éva Szabó-Kriston

Chief Operating Officer, Production Team Lead

Executive Team

Rajmund Lákovics

Chief Operating Officer, Procurement Manager

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 358% MoM, reaching 2.4K.

  • May 17, 2026

    Monthly visitors increased 74% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

StemcellX Filings

Explore SEC and related filing metadata, where available.

StemcellX filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about StemcellX's valuation, stock price, and market status.

Is StemcellX a public or private company?

StemcellX is a private company.

What is the current stock price of StemcellX?

StemcellX is a private company, so its shares have no public market price. Caplight tracks StemcellX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is StemcellX worth (valuation)?

Valuation information for StemcellX is not publicly available.

Can I buy StemcellX stock?

StemcellX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was StemcellX's last funding round?

Funding round information for StemcellX is not publicly available.

Who are the main investors in StemcellX?

Investor information for StemcellX is not publicly disclosed.

Will StemcellX IPO soon?

No public IPO plans have been announced for StemcellX.

How can I track StemcellX secondary market activity?

Caplight tracks bids, offers, and trades in StemcellX's shares on secondary markets.

Firmographic Details

HeadquartersSheffield
Employee Range12
Year Founded2015
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?